The results of the survey can be found here: Precision Medicine Survey
HOPA launched its Precision Oncology Initiative last fall with the goal of advancing the role of oncology pharmacy across the rapidly evolving precision oncology landscape. We are grateful for the engagement of ISOPP in our Stakeholder Interviews. The insights gathered over the last several months have been instrumental in shaping the direction of this work.
We are now bringing those learnings together, and we are happy to invite ISOPP to join us for our Precision Oncology Summit on September 15 in Washington D.C. This full-day event will focus on advancing precision oncology implementation and patient access through the lens of the oncology pharmacist. Clinical practitioners and leaders from across the oncology care continuum will participate in an action-oriented working meeting focused on addressing:
- Precision oncology implementation barriers
- Educational gaps and resource needs
- Integration of oncology pharmacists into precision oncology workflows
- Future trends and opportunities in precision oncology